SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis

GLIA

Volumn 61, Issue 10, 2013, Pages 1659-1672

  Moll, N M ^a,b,c   Hong, E ^d   Fauveau, M ^a,b,c   Naruse, M ^d   Kerninon, C ^a,b,c   Tepavcevic, V ^a,b,c   Klopstein, A ^a,b,c   Seilhean, D ^a,b,c,e   Chew, L J ^d   Gallo, V ^d   Oumesmar, B Nait ^a,b,c,e  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Multiple sclerosis; Oligodendrocyte differentiation; Remyelination; Transcription factors

Indexed keywords

CUPRIZONE; LYSOPHOSPHATIDYLCHOLINE; NEURON SPECIFIC NUCLEAR PROTEIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PROTEIN NOGO A; TRANSCRIPTION FACTOR SOX17;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL DENSITY; CELL DIFFERENTIATION; CELL INFILTRATION; CELL LINEAGE; CELL MATURATION; CELL REGENERATION; CONTROLLED STUDY; DEMYELINATION; DOWN REGULATION; GRAY MATTER; IMMUNOREACTIVITY; MITOSIS; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REMYELINIZATION; UPREGULATION; WHITE MATTER;

MULTIPLE SCLEROSIS; OLIGODENDROCYTE DIFFERENTIATION; REMYELINATION; TRANSCRIPTION FACTORS;

AGED; ANIMALS; ANTIGENS; ANTIGENS, CD45; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN; BROMODEOXYURIDINE; CUPRIZONE; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEIN; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; PROTEOGLYCANS; SOXF TRANSCRIPTION FACTORS; TIME FACTORS; UP-REGULATION;

EID: 84882832971     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22547     Document Type: Article

References (47)

1. Aguirre A, Dupree J, Mangin JM, Gallo V. 2007. A functional role for EGFR signalling in myelination and remyelination. Nat Neurosci 10:990-1002.
2. Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, Kaing S, Raine CS, Rowitch DH, Franklin RJ, Stiles CD. 2004. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 306:2111-2115.
3. Charles P, Reynolds R, Seilhean D, Rougon G, Aigrot MS, Niezgoda A, Zalc B, Lubetzki C. 2002. Re-expression of PSA-NCAM by demyelinated axons: An inhibitor of remyelination in multiple sclerosis? Brain 125:1972-1979.
4. Chew LJ, Gallo V. 2009. The Yin and Yang of Sox proteins: Activation and repression in development and disease. J Neurosci Res 87:3277-3287.
5. Chew LJ, Shen W, Ming X, Senatorov VV Jr, Chen HL, Cheng Y, Hong E, Knoblach S, Gallo V. 2011. SRY-box containing gene 17 regulates the Wnt/β-catenin signaling pathway in oligodendrocyte progenitor cells. J Neurosci 31:13921-13935.
6. Dugas JC, Cuellar TL, Scholze A, Ason B, Ibrahim A, Emery B, Zamanian JL, Foo LC, McManus MT, Barres BA. 2010. Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination. Neuron 65:597-611.
7. Emery B. 2010. Regulation of oligodendrocyte differentiation and myelination. Science 330:779-782.
8. Fancy SP, Kotter MR, Harrington EP, Huang JK, Zhao C, Rowitch DH, Franklin RJ. 2010. Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Exp Neurol 225:18-23.
9. Fancy SP, Baranzini SE, Zhao C, Yuk DI, Irvine KA, Kaing S, Sanai N, Franklin RJ, Rowitch DH. 2009. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 23:1571-1585.
10. Feigenson K, Reid M, See J, Crenshaw EB, III, Grinspan JB. 2009. Wnt signaling is sufficient to perturb oligodendrocyte maturation. Mol Cell Neurosci 42:255-265.
11. Franklin RJ, Ffrench-Constant C. 2008. Remyelination in the CNS: From biology to therapy. Nat Rev Neurosci 9:839-855.
12. Jablonska B, Aguirre A, Vandenbosch R, Belachew S, Berthet C, Kaldis P, Gallo V. 2007. Cdk2 is critical for proliferation and self-renewal of neural progenitor cells in the adult subventricular zone. J Cell Biol 179:1231-1245.
13. Jeffery ND, Blakemore WF. 1995. Remyelination of mouse spinal cord axons demyelinated by local injection of lysolecithin. J Neurocytol 24:775-781.
14. Kitada M, Rowitch DH. 2006. Transcription factor co-expression patterns indicate heterogeneity of oligodendroglial subpopulations in adult spinal cord. Glia 54:35-46.
15. Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H. 2000. Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157:267-276.
16. Kuhlbrodt K, Herbarth B, Sock E, Hermans-Borgmeyer I, Wegner M. 1998. Sox10, a novel transcriptional modulator in glial cells. J Neurosci 18:237-250.
17. Kuhlmann T, Miron V, Cui Q, Wegner C, Antel J, Bruck W. 2008. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain; 131:1749-1758.
18. Lassmann H. 1998. Neuropathology in multiple sclerosis: New concepts. Mult Scler 4:93-98.
19. Ligon KL, Kesari S, Kitada M, Sun T, Arnett HA, Alberta JA, Anderson DJ, Stiles CD, Rowitch DH. 2006. Development of NG2 neural progenitor cells requires Olig gene function. Proc NarticleTitle Acad Sci USA 103:7853-7858.
20. Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD, Rowitch DH. 2002. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 109:75-86.
21. Lubetzki C, Williams A, Stankoff B. 2005. Promoting repair in multiple sclerosis: Problems and prospects. Curr Opin Neurol 18:237-244.
22. Mason JL, Ye P, Suzuki K, D'Ercole AJ, Matsushima GK. 2000. Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J Neurosci 20:5703-5708.
23. Mason JL, Toews A, Hostettler JD, Morell P, Suzuki K, Goldman JE, Matsushima GK. 2004. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am J Pathol; 164:1673-1682.
24. Matsushima GK, Morell P. 2001. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11:107-116.
25. Mi S, Miller RH, Tang W, Lee X, Hu B, Wu W, Zhang Y, Shields CB, Zhang Y, Miklasz S, Shea D, Mason J, Franklin RJ, Ji B, Shao Z, Chédotal A, Bernard F, Roulois A, Xu J, Jung V, Pepinsky B. 2009. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol 65:304-315.
26. Nait Oumesmar B, Vignais L, Duhamel-Clerin E, Avellana-Adalid V, Rougon G, Baron-Van Evercooren A. 1995. Expression of the highly polysialylated neural cell adhesion molecule during postnatal myelination and following chemically induced demyelination of the adult mouse spinal cord. Eur J Neurosci 7:480-491.
27. Niakan KK, Ji H, Maehr R, Vokes SA, Rodolfa KT, Sherwood RI, Yamaki M, Dimos JT, Chen AE, Melton DA, McMahon AP, Eggan K. 2010. Sox17 promotes differentiation in mouse embryonic stem cells by directly regulating extraembryonic gene expression and indirectly antagonizing self-renewal. Genes Dev 24:312-326.
28. Nishiyama A, Komitova M, Suzuki R, Zhu X. 2009. Polydendrocytes (NG2 cells): Multifunctional cells with lineage plasticity. Nat Rev Neurosci 10:9-22.
29. Park KS, Wells JM, Zorn AM, Wert SE, Whitsett JA. 2006. Sox17 influences the differentiation of respiratory epithelial cells. Dev Biol 294:192-202.
30. Peru RL, Mandrycky N, Nait-Oumesmar B, Lu QR. 2008. Paving the axonal highway: From stem cells to myelin repair. Stem Cell Rev 4:304-318.
31. Reynolds R, Hardy R. 1997. Oligodendroglial progenitors labeled with the O4 antibody persist in the adult rat cerebral cortex in vivo. J Neurosci Res 47:455-470.
32. Rowitch DH, Kriegstein AR. 2010. Developmental genetics of vertebrate glial-cell specification. Nature 468:214-222.
33. Shimizu T, Kagawa T, Wada T, Muroyama Y, Takada S, Ikenaka K. 2005. Wnt signaling controls the timing of oligodendrocyte development in the spinal cord. Dev Biol 282:397-410.
34. Shin D, Shin JY, McManus MT, Ptacek LJ, Fu YH. 2009. Dicer ablation in oligodendrocytes provokes neuronal impairment in mice. Ann Neurol 66:843-857.
35. Sinner D, Rankin S, Lee M, Zorn AM. 2004. Sox17 and beta-catenin cooperate to regulate the transcription of endodermal genes. Development 131:3069-3080.
36. Sinner D, Kordich JJ, Spence JR, Opoka R, Rankin S, Lin SC, Jonatan D, Zorn AM, Wells JM. 2007. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol Cell Biol 27:7802-7815.
37. Sohn J, Natale J, Chew LJ, Belachew S, Cheng Y, Aguirre A, Lytle J, Nait-Oumesmar B, Kerninon C, Kanai-Azuma M, Kanai Y, Gallo V. 2006. Identification of Sox17 as a transcription factor that regulates oligodendrocyte development. J Neurosci 26:9722-9735.
38. Stadelmann C, Bruck W. 2008. Interplay between mechanisms of damage and repair in multiple sclerosis. J Neurol 255:12-18.
39. Tallantyre EC, Bo L, Al-Rawashdeh O, Owens T, Polman CH, Lowe J, Evangelou N. 2009. Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease. Brain 132:1190-1199.
40. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. 1998. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285.
41. Watanabe M, Toyama Y, Nishiyama A. 2002. Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion. J Neurosci Res 69:826-836.
42. Wegner M, Stolt CC. 2005. From stem cells to neurons and glia: A Soxist's view of neural development. Trends Neurosci 28:583-588.
43. Wolswijk G. 2002. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 125:338-349.
44. Woodruff RH, Franklin RJ. 1999. Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: A comparative study. Glia 25:216-228.
45. Ye F, Chen Y, Hoang T, Montgomery RL, Zhao XH, Bu H, Hu T, Taketo MM, van Es JH, Clevers H, Hsieh J, Bassel-Duby R, Olson EN, Lu QR. 2009. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nat Neurosci 12:829-838.
46. Zhang Y, Argaw AT, Gurfein BT, Zameer A, Snyder BJ, Ge C, Lu QR, Rowitch DH, Raine CS, Brosnan CF, John GR. 2009. Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination. Proc NarticleTitle Acad Sci USA 106:19162-19167.
47. Zhou Q, Anderson DJ. 2002. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 109:61-73.